Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Sep-30-22 | Sep-05-22 | Sep-30-21 | Sep-05-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 |
| | 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Royalties | 30.3 | | 30.8 | | 28.6 | 34.8 | 30.6 | 30.3 |
| Product Sales | 27.9 | | 21.8 | | 21.6 | 18.6 | 17.2 | 13.7 |
| License Fees | 6.0 | | 16.3 | | 12.0 | 13.7 | 4.8 | 1.5 |
| Other | 8.2 | | 9.4 | | 9.2 | 11.3 | 7.9 | 8.5 |
| Medical Device revenues | 72.4 | | 78.3 | | 71.4 | 78.4 | 60.5 | 54.0 |
| Revenue growth [+] | -7.5% | | 9.6% | | -8.9% | 29.5% | 12.1% | 1.5% |
| Royalties | -1.7% | | 7.6% | | -17.7% | 13.6% | 1.1% | |
| Product Sales | 28.3% | | 0.8% | | 16.1% | 8.2% | 25.2% | |
| License Fees | -63.3% | | 35.4% | | -12.1% | 183.9% | 230.9% | |
| EBITDA | -14.6 | | 11.9 | | 3.0 | 10.6 | -3.1 | 11.4 |
| EBITDA margin | -20.1% | | 15.2% | | 4.2% | 13.5% | -5.1% | 21.0% |
| Depreciation and amortization | 8.4 | | 7.2 | | 6.2 | 5.8 | 5.4 | 4.5 |
| EBIT | -22.9 | | 4.7 | | -3.2 | 4.8 | -8.5 | 6.9 |
| EBIT margin | -31.7% | | 6.0% | | -4.5% | 6.1% | -14.0% | 12.8% |
| |
| Revenue Mix | 72.4% | | 74.4% | | 75.3% | 78.3% | 74.4% | 73.8% |
| EBIT Mix | | | 71.7% | | | 74.1% | | 97.2% |
|